Add like
Add dislike
Add to saved papers

Facile synthesis of ZrO 2 coated BiOCl 0.5 I 0.5 for photocatalytic oxidation-adsorption of As(III) under visible light irradiation.

Chemosphere 2018 November
ZrO2 modified BiOCl0.5 I0.5 composites (ZBCI), synthesized via a facile precipitation method at room temperature, were utilized to photocatalytically oxidize and adsorb arsenite from water under visible light irradiation. The composites were well characterized by using various techniques. With visible light irradiation, 5 mg L-1 of As(III) could be completely removed by ZBCI (0.25 g L-1 ) in 90 min. Particularly, we found that ZBCI composites not only could oxidize As(III) into As(V) with visible light irradiation, but also could effectively capture the generated As(V), leading to the negligible residual As(III) or As(V) in aqueous solutions after 90 min treatment. In the fabricated composites, ZrO2 acted as the main adsorption sites while BiOCl0.5 I0.5 served as the primary photocatalysis center. Because of the heterostructure of ZBCI, e- generated by BiOCl0.5 I0.5 would be transferred to ZrO2 and inhibited e- -h+ recombination rate, contributing to the improved photocatalytic efficiency. ZBCI could effectively remove As(III) over a broad range of pH from 3 to 11. Chloride and nitrate did not obviously affect the photocatalytic As(III) removal, while sulfate and phosphate yet reduced the capture of As(III). Moreover, ZBCI composites exhibited high photocatalytic As(III) removal efficiency during the fourth reused cycles. The facile synthesized ZBCI could be employed to capture and oxidize As(III) from water.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app